Trial intelligence / Profile preview

Liposomal Bupivacaine in Ankle Fracture Surgery

NCT02480621Phase 3Completed

Sponsor
Jamaica Hospital Medical Center
Start
Dec 2014
Primary completion
Jun 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Jamaica Hospital Medical Center. Primary endpoint: Pain Levels on a Visual Analog Scale at 72 hours. Started Dec 2014; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02480621.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02480621.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call